Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Net Asset Quality Index
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Net Asset Quality Index of 90.1% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.13 Billion minus total liabilities of CN¥211.52 Million yields net assets of CN¥1.92 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Suzhou Fushilai Pharmaceutical Co. Ltd. Net Asset Quality Index Over Time (2019–2024)
This chart shows how Suzhou Fushilai Pharmaceutical Co. Ltd.'s Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 90.1%, representing net assets of CN¥1.92 Billion against total assets of CN¥2.13 Billion CNY. Explore 301258 cash flow metrics to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
The table below presents the year-by-year Net Asset Quality Index for Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 90.4% | CN¥1.89 Billion | CN¥2.09 Billion | CN¥200.84 Million | ▼ -1.6 pp |
| 2023 | 91.9% | CN¥1.95 Billion | CN¥2.12 Billion | CN¥170.45 Million | ▲ +2.0 pp |
| 2022 | 89.9% | CN¥1.89 Billion | CN¥2.10 Billion | CN¥211.75 Million | ▲ +13.4 pp |
| 2021 | 76.6% | CN¥742.84 Million | CN¥970.31 Million | CN¥227.47 Million | ▼ -2.4 pp |
| 2020 | 79.0% | CN¥622.64 Million | CN¥788.25 Million | CN¥165.61 Million | ▲ +1.5 pp |
| 2019 | 77.4% | CN¥581.96 Million | CN¥751.44 Million | CN¥169.48 Million | — |